# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001659617-18-000027
Filing Date
2018-03-28
Accepted
2018-03-28 08:17:06
Documents
73
Period of Report
2017-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-K | a2017q410-k.htm | 10-K | 1319545
2 | EXHIBIT 23.1 | a2017q410-kexhibit231.htm | EX-23.1 | 3005
3 | EXHIBIT 31.1 | a2017q410-kexhibit311.htm | EX-31.1 | 9117
4 | EXHIBIT 31.2 | a2017q410-kexhibit312.htm | EX-31.2 | 9136
5 | EXHIBIT 32.1 | a2017q410-kexhibit321.htm | EX-32.1 | 5835
6 | EXHIBIT 32.2 | a2017q410-kexhibit322.htm | EX-32.2 | 5870
13 |  | cancerindustrychart.jpg | GRAPHIC | 20452
14 |  | pg1img1_10k.jpg | GRAPHIC | 11270
15 |  | pg11img1_10k.jpg | GRAPHIC | 75314
16 |  | pg13img1_10k.jpg | GRAPHIC | 108039
17 |  | pg14img1_10k.jpg | GRAPHIC | 33471
18 |  | wp1122inmice.jpg | GRAPHIC | 18113
| Complete submission text file | 0001659617-18-000027.txt |  | 7288982

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
7 | XBRL INSTANCE DOCUMENT | mbrx-20171231.xml | EX-101.INS | 1183371
8 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | mbrx-20171231.xsd | EX-101.SCH | 70222
9 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | mbrx-20171231_cal.xml | EX-101.CAL | 72494
10 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | mbrx-20171231_def.xml | EX-101.DEF | 311708
11 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | mbrx-20171231_lab.xml | EX-101.LAB | 848929
12 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | mbrx-20171231_pre.xml | EX-101.PRE | 473934

Mailing Address 2575 WEST BELLFORT SUITE 333 HOUSTON TX 77054
Business Address 2575 WEST BELLFORT SUITE 333 HOUSTON TX 77054 713-300-5160
Moleculin Biotech, Inc. (Filer) CIK: 0001659617 (see all company filings)

EIN.: 474671999 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37758 | Film No.: 18717063
SIC: 2834 Pharmaceutical Preparations